Brief: Klaria Pharma Reports Successful Outcome Of Pivotal Bioequivalence Study With Sumatriptan Alginate Film

Klaria Pharma Holding AB (publ)

06/05/2021 06:48

May 6 (Reuters) - Klaria Pharma Holding AB  KLAR.ST :
    * SAID ON WEDNESDAY KLARIA ANNOUNCES SUCCESSFUL OUTCOME OF
PIVOTAL
BIOEQUIVALENCE STUDY WITH SUMATRIPTAN ALGINATE FILM 
    * REPORTS THAT SUMATRIPTAN ALGINATE FILM HAS DEMONSTRATED
BIOEQUIVALENCE TO BOTH OF THE US AND EU APPROVED COMPARATOR
SUMATRIPTAN NASAL SPRAY PRODUCTS
    * CLINICAL TRIAL DATA SHOW THAT SUMATRIPTAN ALGINATE FILM
HAS
DEMONSTRATED A LOWER INTER-SUBJECT VARIABILITY THAN EITHER THE
US OR EU SUMATRIPTAN NASAL SPRAY
    * NO SERIOUS ADVERSE EVENTS WERE REPORTED FOR ANY OF THE
PRODUCTS
INVOLVED IN THE STUDY

    
    
 Source text for Eikon:  urn:newsml:reuters.com:*:nWkr3tNSqS
    
 Further company coverage:  KLAR.ST  
   


 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00))